$EVFM I think most of us on this board are here because we believe in PHEXXI and that management will continue to learn and get better. I am very bullish and have a hard time seeing this investment as a risky one. I think we will see sales increase quickly next year with improved marketing and as we expand worldwide the opportunity is enormous. With me being blindsided by positive thoughts what could be some of the risks I’m missing? Obviously if sales don’t meet expectations we will need to do another offering which is dilution. They could sell out early for a low price, EVO 100 could be denied from FDA but they seem pretty set on this and so does Adjuvant. We could also see a competitor eventually but is a ways down the road. I hope I don’t get any responses to this but I know there will be some insight into the risks lol. Cheers.
  • 9